DIAMEDICA THERAPEUTICS INC (DMAC) Stock Analyst Earnings Estimates
NASDAQ:DMAC - Nasdaq - CA25253X2077 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 500K | -100.00% | 11.369M | 41.502M 265.05% | 80.162M 93.15% | 120.87M 50.78% | 150.87M 24.82% | 175.86M 16.56% | ||||||||||
| EBITDA YoY % growth | -2.479M -71.90% | -4.515M -82.11% | -6.746M -49.41% | -11.233M -71.54% | -11.016M -9.56% | N/A -7.45% | N/A -2.60% | -21.216M -51.95% | -26.622M -25.45% | -40.596M -52.38% | -39.27M 3.27% | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -2.482M -71.52% | -4.519M -82.11% | -6.761M -49.61% | -12.09M -71.47% | -12.107M -9.54% | -15.531M -7.46% | -14.069M -2.60% | -21.46M -51.90% | -26.539M -25.46% | -35.587M -33.38% | -39.161M -10.04% | -42.613M -8.82% | -22.926M 46.20% | 1.72M 107.50% | 27.712M 1,511.16% | 49.632M 79.10% | 70.795M 42.64% | |
| Operating Margin | N/A | N/A | -1,352.20% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | -374.81% | -55.24% | 2.15% | 22.93% | 32.90% | 40.26% | |
| EPS YoY % growth | N/A | N/A | N/A | -0.95 -9.07% | -0.74 12.36% | -0.74 17.95% | -0.53 18.75% | -0.62 -19.23% | -0.60 3.23% | -0.79 -32.03% | -0.81 -2.58% | -0.91 -11.72% | -0.46 49.44% | 0.08 117.78% | 0.50 512.50% | 0.87 73.47% | 1.21 40.00% |
All data in USD
| Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.20 -33.74% | -0.21 -19.00% | -0.19 -7.67% | -0.19 -7.67% | -0.19 3.39% | -0.19 9.52% |
| Revenue Q2Q % growth | ||||||
| EBITDA Q2Q % growth | -10.71M -56.24% | -11.73M -39.98% | -10.302M -26.67% | -9.792M -1.05% | -9.792M 8.57% | -9.792M 16.52% |
| EBIT Q2Q % growth | -9.081M -31.93% | -9.551M -13.45% | -10.302M -26.50% | -9.792M -12.83% | -9.792M -7.83% | -9.792M -2.52% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | -0.18 -38.46% | -0.19 | 0.01 | 7.12% |
| Q1 2025 Q2Q % growth | -0.18 -28.57% | -0.18 | 0.00 | 1.96% |
| Q4 2024 Q2Q % growth | -0.18 -28.57% | -0.18 | 0.00 | -2.30% |
| Q3 2024 Q2Q % growth | -0.15 -25.00% | -0.16 | 0.01 | 5.12% |
| Q2 2024 Q2Q % growth | -0.13 18.75% | -0.16 | 0.03 | 18.65% |
| Q1 2024 Q2Q % growth | -0.14 30.00% | -0.16 | 0.02 | 12.39% |
| Q4 2023 Q2Q % growth | -0.14 | -0.14 | 0.00 | 1.96% |
| Q3 2023 Q2Q % growth | -0.12 | -0.13 | 0.01 | 7.12% |
| Q2 2023 Q2Q % growth | -0.16 -23.08% | -0.18 | 0.02 | 11.21% |
| Q1 2023 Q2Q % growth | -0.20 -53.85% | -0.16 | -0.04 | -22.55% |
| Q4 2022 Q2Q % growth | -0.14 -40.00% | -0.14 | 0.00 | 1.96% |
| Q3 2022 Q2Q % growth | -0.12 33.33% | -0.15 | 0.03 | 20.24% |
| Q2 2022 Q2Q % growth | -0.13 23.53% | -0.18 | 0.05 | 29.19% |
| Q1 2022 Q2Q % growth | -0.13 31.58% | -0.22 | 0.09 | 40.26% |
| Q4 2021 Q2Q % growth | -0.10 56.52% | -0.18 | 0.08 | 44.30% |
| Q3 2021 Q2Q % growth | -0.18 5.26% | -0.23 | 0.05 | 22.60% |
| Q2 2021 Q2Q % growth | -0.17 | -0.22 | 0.05 | 21.26% |
| Q1 2021 Q2Q % growth | -0.19 | -0.22 | 0.03 | 12.68% |
| Q4 2020 Q2Q % growth | -0.23 -9.52% | -0.17 | -0.06 | -34.22% |
| Q3 2020 Q2Q % growth | -0.19 5.00% | -0.15 | -0.04 | -27.00% |
| Q2 2020 Q2Q % growth | -0.17 19.05% | -0.16 | -0.01 | -8.70% |
| Q1 2020 Q2Q % growth | -0.19 29.63% | -0.29 | 0.10 | 34.26% |
| Q4 2019 Q2Q % growth | -0.21 | -0.25 | 0.04 | 17.21% |
| Q3 2019 Q2Q % growth | -0.20 | -0.21 | 0.01 | 6.63% |
| Q2 2019 Q2Q % growth | -0.21 | -0.26 | 0.05 | 19.79% |
| Q1 2019 Q2Q % growth | -0.27 | -0.20 | -0.07 | -32.35% |
| Period | Reported | Estimate | Difference | Surprise |
|---|
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | -3.64% | 0% | -1.75% |
| Revenue | N/A | N/A | N/A | N/A |